Emmanuel Mignot
Emmanuel Mignot
Verified email at stanford.edu - Homepage
Title
Cited by
Cited by
Year
The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
L Lin, J Faraco, R Li, H Kadotani, W Rogers, X Lin, X Qiu, PJ de Jong, ...
Cell 98 (3), 365-376, 1999
27311999
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index
S Taheri, L Lin, D Austin, T Young, E Mignot
PLoS medicine 1 (3), e62, 2004
26032004
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
C Peyron, J Faraco, W Rogers, B Ripley, S Overeem, Y Charnay, ...
Nature medicine 6 (9), 991-997, 2000
21122000
Hypocretin (orexin) deficiency in human narcolepsy
S Nishino, B Ripley, S Overeem, GJ Lammers, E Mignot
The Lancet 355 (9197), 39-40, 2000
18352000
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias
E Mignot, GJ Lammers, B Ripley, M Okun, S Nevsimalova, S Overeem, ...
Archives of neurology 59 (10), 1553-1562, 2002
11392002
Dopaminergic role in stimulant-induced wakefulness
JP Wisor, S Nishino, I Sora, GH Uhl, E Mignot, DM Edgar
Journal of Neuroscience 21 (5), 1787-1794, 2001
7802001
Narcolepsy with cataplexy
Y Dauvilliers, I Arnulf, E Mignot
The Lancet 369 (9560), 499-511, 2007
7252007
Genetic and familial aspects of narcolepsy
E Mignot
Neurology 50 (2 Suppl 1), S16-S22, 1998
6761998
A CLOCK Polymorphism Associated with Human Diurnal Preference
D Katzenberg, T Young, L Finn, L Lin, DP King, JS Takahashi, E Mignot
Sleep 21 (6), 569-576, 1998
6641998
Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups
E Mignot, L Lin, W Rogers, Y Honda, X Qiu, X Lin, M Okun, H Hohjoh, ...
The American Journal of Human Genetics 68 (3), 686-699, 2001
6072001
Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy
S Nishino, B Ripley, S Overeem, S Nevsimalova, GJ Lammers, J Vankova, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
4932001
Pharmacological aspects of human and canine narcolepsy
S Nishino, E Mignot
Progress in neurobiology 52 (1), 27-78, 1997
4721997
Narcolepsy is strongly associated with the T-cell receptor alpha locus
J Hallmayer, J Faraco, L Lin, S Hesselson, J Winkelmann, M Kawashima, ...
Nature genetics 41 (6), 708-711, 2009
4692009
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China
F Han, L Lin, SC Warby, J Faraco, J Li, SX Dong, P An, L Zhao, LH Wang, ...
Annals of neurology 70 (3), 410-417, 2011
4612011
HLA DQB1* 0602 is associated with cataplexy in 509 narcoleptic patients
E Mignot, R Hayduk, J Black, FC Grumet, C Guilleminault
Sleep 20 (11), 1012-1020, 1997
4611997
Fluctuation of extracellular hypocretin‐1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities
Y Yoshida, N Fujiki, T Nakajima, B Ripley, H Matsumura, H Yoneda, ...
European Journal of Neuroscience 14 (7), 1075-1081, 2001
4542001
CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
B Ripley, S Overeem, N Fujiki, S Nevsimalova, M Uchino, J Yesavage, ...
Neurology 57 (12), 2253-2258, 2001
4322001
Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders
E Mignot, S Taheri, S Nishino
Nature neuroscience 5 (11), 1071-1075, 2002
4272002
Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives
S Overeem, E Mignot, J GertvanDijk, GJ Lammers
Journal of Clinical Neurophysiology 18 (2), 78-105, 2001
4142001
The role of hypocretins (orexins) in sleep regulation and narcolepsy
S Taheri, JM Zeitzer, E Mignot
Annual review of neuroscience 25 (1), 283-313, 2002
4062002
The system can't perform the operation now. Try again later.
Articles 1–20